title: Adjuvant valproate therapy for patients with suspected mixed-depressive features.
abstract: OBJECTIVE
  Mixed-depressive features imply an occult bipolarity and might be linked to resistance to antidepressant therapy and a higher risk of suicide. Currently, there is no consensus about or any clinical guidelines available for this ill-defined clinical entity. The aim of this study was to assess the effectiveness, safety, and tolerability of mood stabilizers, such as valproate, for adjuvant therapy in patients suspected of having mixed-depressive features.
  
  
  METHODS
  This retrospective observational study reviewed medical records of psychiatric outpatients attended by the author from 2008 to 2013. Patients who presented with inadequately treated, long-lasting atypical depressive- and/or anxiety-spectrum symptoms, and who started adjuvant valproate therapy for the first time in their course of treatment, were identified. Patient demographics, clinical profiles, treatment responses, and treatment-emergent adverse events (AEs) were examined in detail.
  
  
  RESULTS
  A total of 22 patients (7 men and 15 women) ranging in age between 25 and 78 years were treated with valproate 100-1250 mg/day and observed for 3-60 months. The majority exhibited much or moderate improvement, and only four showed a limited response. During follow up, 12 continued adjuvant valproate, 3 were intermittent users, and 3 quit after no apparent response; 4 experienced an aggravation of symptoms after discontinuation but were stabilized soon after reinstitution. AEs were reported by 12 patients and 4 stopped valproate for intolerability despite improvement.
  
  
  CONCLUSIONS
  Adjuvant valproate therapy seems to be a promising approach to treating patients who manifest atypical neurotic or mood disorders with subthreshold bipolarity at a dosage around the lower end of that used to treat full-syndromal bipolar disorders.
authors.affiliation: Department of Psychiatry, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, 10002, Taiwan.
authors.forename: Chen-Chung
authors.initials: CC
authors.lastname: Liu
keywords: adjuvant therapy; bipolarity; depressive-mixed states; mixed-depressive features; valproate
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):932-9
references.pmid: 18234411
references.citation: Int Rev Psychiatry. 2005 Feb;17(1):21-37
references.pmid: 16194768
references.citation: J Affect Disord. 2010 Mar;121(3):199-203
references.pmid: 19556009
references.citation: J Affect Disord. 2012 Jan;136(1-2):e13-e19
references.pmid: 21621266
references.citation: Lancet. 2007 Mar 17;369(9565):935-45
references.pmid: 17368155
references.citation: J Psychopharmacol. 2009 Mar;23(2):220-2
references.pmid: 18515466
references.citation: Acta Psychiatr Scand. 2014 Jan;129(1):4-16
references.pmid: 23600771
references.citation: Eur Psychiatry. 2008 Jan;23(1):40-8
references.pmid: 17764909
references.citation: J Affect Disord. 2010 Dec;127(1-3):10-8
references.pmid: 20655113
references.citation: Am J Psychiatry. 2009 Feb;166(2):127-30
references.pmid: 19188286
references.citation: J Affect Disord. 2013 May 15;148(1):28-36
references.pmid: 23561484
references.citation: J Affect Disord. 2005 Feb;84(2-3):243-9
references.pmid: 15708422
references.citation: J Clin Psychiatry. 2007 Dec;68(12):1840-4
references.pmid: 18162014
references.citation: J Affect Disord. 2005 Apr;85(3):245-58
references.pmid: 15780694